Photobooths had the pleasure of meeting Warren & Samantha Mowle, owners of Kent based charity, Stacey’s Smiles.
Stacey’s Smiles is a registered charity that was set up by parents Warren & Samantha, following the saddening loss of their daughter Stacey. Stacey was only 4 years old when she was diagnosed with Stage 4 Neuroblastoma Cancer, and sadly passed away 5 years later at the age of 9 in 2015.
Following their loss, Warren & Samantha have been devoted to create a fitting legacy to Stacey, who always loved to bring a smile to others around her. The heart warming charity is devoted to bringing smiles to children and families who are dealing with neuroblastoma cancer by fundraising, and hosting various activities, such as special days out, delivering special gifts, organising holidays, and specially organised parties.
Stacey’s Smiles have ordered the Magic Mirror Booth SE from Photobooths to use at their function and events held throughout the year, including dedicated parties at specialist cancer hospitals such as The Royal Marsden, Sutton, Surrey. Owner Warren says that he believes the Magic Mirror will “be used by everyone within these parties to create amazing fun memories “
Warren also adds the Mirror will be used at “specially arranged house and hospital parties, for children who are not well enough to leave the 4 walls of the hospital or the 4 walls of their home”
To encourage further fundraising for the charity, Warren plans to also market the mirror available to hire for private functions, such as weddings and birthdays.
Photobooths look forward to meeting with Stacey’s Smiles on the day of their collection, and are delighted to have been a part of their story for this magnificent charity. We will be continuously keeping in touch to show our support.
Stacey’s Smiles is a registered charity that fundraises to grant wishes for children and their families dealing with Neuroblastoma Cancer. The charity was set up by the parents of Stacey Mowle, who lost her fight on March 6th 2015 after 5 years battling High Risk Stage 4 Neuroblastoma Cancer.